Eton Pharmaceuticals (ETON) Debt to Equity (2020 - 2025)
Historic Debt to Equity for Eton Pharmaceuticals (ETON) over the last 6 years, with Q3 2025 value amounting to $1.31.
- Eton Pharmaceuticals' Debt to Equity rose 40872.3% to $1.31 in Q3 2025 from the same period last year, while for Sep 2025 it was $1.31, marking a year-over-year increase of 40872.3%. This contributed to the annual value of $1.22 for FY2024, which is 25106.95% up from last year.
- As of Q3 2025, Eton Pharmaceuticals' Debt to Equity stood at $1.31, which was up 40872.3% from $1.26 recorded in Q2 2025.
- Eton Pharmaceuticals' 5-year Debt to Equity high stood at $1.31 for Q3 2025, and its period low was $0.02 during Q1 2021.
- In the last 5 years, Eton Pharmaceuticals' Debt to Equity had a median value of $0.09 in 2023 and averaged $0.34.
- Its Debt to Equity has fluctuated over the past 5 years, first tumbled by 2389.89% in 2022, then soared by 40872.3% in 2025.
- Over the past 5 years, Eton Pharmaceuticals' Debt to Equity (Quarter) stood at $0.08 in 2021, then dropped by 1.79% to $0.08 in 2022, then soared by 340.08% to $0.35 in 2023, then skyrocketed by 251.07% to $1.22 in 2024, then rose by 7.6% to $1.31 in 2025.
- Its Debt to Equity stands at $1.31 for Q3 2025, versus $1.26 for Q2 2025 and $1.22 for Q4 2024.